Sélection 2015
Tourneau, C.L et al.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Lancet Oncol.
doi: 10.1016/S1470-2045(15)00188-6
Portal MM. et al.
TARDIS, a targeted RNA directional sequencing method for rare RNA discovery.
Nat Protoc. (2015) (12):1915-38.
doi: 10.1038/nprot.2015.120
Thierry A. et al.
Macrotene chromosomes provide insights to a new mechanism of high-order gene amplification in eukaryotes.
Nat Commun. (2015) 6:6154.
doi: 10.1038/ncomms7154
Crottès D.et al.
SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.
Cancer Res. 76(3):607-18.
doi: 10.1158/0008-5472.CAN-15-1465
Carradec Q. et al.
Primary and secondary siRNA synthesis triggered by RNAs from food bacteria in the ciliate Paramecium tetraurelia.
Nucleic Acids Res. (2015) 43(3):1818-33.
doi: 10.1093/nar/gku1331
Prasad MK et al.
A targeted next-generation sequencing assay for the molecular diagnosis of genetic disorders with orodental involvement.
J Med Genet. Epub 2015 Oct 26.
doi: 10.1136/jmedgenet-2015-103302
Boulay AC. et al.
Immune quiescence of the brain is set by astroglial connexin 43.
J Neurosci. (2015)
doi: 10.1523/JNEUROSCI.2575-14.2015
Kopylova E. et al.
Deciphering metatranscriptomic data.
Methods in molecular biology (Clifton, NJ), (2015) 1269:279-291.
doi: 10.1007/978-1-4939-2291-8_17
Al Adhami H et al.
A systems-level approach to parental genomic imprinting: the imprinted gene network includes extracellular matrix genes and regulates cell cycle exit and differentiation.
Genome Res. (2015)
doi: 10.1101/gr.175919.114
Laurette P. et al.
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Elife. (2015) 4.
doi: 10.7554/eLife.06857